Disinfectants struggling to kill C. diff bacteria

Clostridioides difficile is challenging hospital-grade disinfectants


Clostridioides difficile (C Diff.) is challenging hospital-grade disinfectants meant to kill it, according to an article on the Medical Express website.

Results of a new study found that no disinfectant was able to completely eliminate C. difficile embedded within biofilms.

No previous studies have investigated chemical disinfection of C. diff spores embedded in biofilms. 

The Centers for Disease Control and Prevention report that within a month of diagnosis, one in 11 people over age 65 died of a health care-associated C. diff infection. 

Read the article.



November 15, 2019


Topic Area: Infection Control


Recent Posts

Building Envelopes Emerge As Key Facility Components

From enclosure commissioning and air-moisture control to decarbonization and thermal comfort, exterior systems affect energy efficiency and resilience.


Catholic Medical Center Breaks Ground on New Central Energy Plant

The new central energy plant is expected to be completed in early 2027.


Cottage Hospital Ensnared in Data Breach

On December 8, 2025, Cottage Hospital learned that an unauthorized party gained access to its computer network and took some of its files.


Biofilm 'Life Raft' Changes C. Auris Risk

Microscopic survival structure protects fungal pathogen from disinfectants and help it survive for long periods.


How Healthcare Restrooms Are Rethinking Water Efficiency

Manufacturers discuss strategies, technologies and design approaches that help healthcare facilities meet their sustainability goals.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.